These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31726465)

  • 41. Inhibition of Na+ transport in lung epithelial cells by respiratory syncytial virus infection.
    Chen L; Song W; Davis IC; Shrestha K; Schwiebert E; Sullender WM; Matalon S
    Am J Respir Cell Mol Biol; 2009 May; 40(5):588-600. PubMed ID: 18952569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF.
    McNamara PS; Fonceca AM; Howarth D; Correia JB; Slupsky JR; Trinick RE; Al Turaiki W; Smyth RL; Flanagan BF
    Thorax; 2013 Jan; 68(1):76-81. PubMed ID: 23002173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection.
    Morris D; Ansar M; Speshock J; Ivanciuc T; Qu Y; Casola A; Garofalo R
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31398832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells.
    Gómez RS; Ramirez BA; Céspedes PF; Cautivo KM; Riquelme SA; Prado CE; González PA; Kalergis AM
    Immunology; 2016 Jan; 147(1):55-72. PubMed ID: 26451966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease.
    Baier C; Haid S; Beilken A; Behnert A; Wetzke M; Brown RJP; Schmitt C; Ebadi E; Hansen G; Schulz TF; Pietschmann T; Bange FC
    Antimicrob Resist Infect Control; 2018; 7():21. PubMed ID: 29449938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of respiratory syncytial virus infection on dendritic cells and cysteinyl leukotrienes in lung tissues of a murine model of asthma.
    Matsuse H; Hirose H; Tsuchida T; Fukahori S; Fukushima C; Mizuta Y; Kohno S
    Allergol Int; 2007 Jun; 56(2):165-9. PubMed ID: 17460444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells.
    Malhotra R; Ward M; Bright H; Priest R; Foster MR; Hurle M; Blair E; Bird M
    Microbes Infect; 2003 Feb; 5(2):123-33. PubMed ID: 12650770
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RSV infection of human airway epithelial cells causes production of the beta-chemokine RANTES.
    Becker S; Reed W; Henderson FW; Noah TL
    Am J Physiol; 1997 Mar; 272(3 Pt 1):L512-20. PubMed ID: 9124609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand.
    Kotelkin A; Prikhod'ko EA; Cohen JI; Collins PL; Bukreyev A
    J Virol; 2003 Sep; 77(17):9156-72. PubMed ID: 12915532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting Intracellular Ion Homeostasis for the Control of Respiratory Syncytial Virus.
    Norris MJ; Malhi M; Duan W; Ouyang H; Granados A; Cen Y; Tseng YC; Gubbay J; Maynes J; Moraes TJ
    Am J Respir Cell Mol Biol; 2018 Dec; 59(6):733-744. PubMed ID: 30095982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disruption of the airway epithelial barrier in a murine model of respiratory syncytial virus infection.
    Smallcombe CC; Linfield DT; Harford TJ; Bokun V; Ivanov AI; Piedimonte G; Rezaee F
    Am J Physiol Lung Cell Mol Physiol; 2019 Feb; 316(2):L358-L368. PubMed ID: 30489157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical characteristics and viral load of respiratory syncytial virus and human metapneumovirus in children hospitaled for acute lower respiratory tract infection.
    Yan XL; Li YN; Tang YJ; Xie ZP; Gao HC; Yang XM; Li YM; Liu LJ; Duan ZJ
    J Med Virol; 2017 Apr; 89(4):589-597. PubMed ID: 27632796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium.
    Guo-Parke H; Canning P; Douglas I; Villenave R; Heaney LG; Coyle PV; Lyons JD; Shields MD; Power UF
    Am J Respir Crit Care Med; 2013 Oct; 188(7):842-51. PubMed ID: 23952745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells.
    Arnold R; Neumann M; König W
    Immunology; 2007 May; 121(1):71-81. PubMed ID: 17425601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutation of Respiratory Syncytial Virus G Protein's CX3C Motif Attenuates Infection in Cotton Rats and Primary Human Airway Epithelial Cells.
    Ha B; Chirkova T; Boukhvalova MS; Sun HY; Walsh EE; Anderson CS; Mariani TJ; Anderson LJ
    Vaccines (Basel); 2019 Jul; 7(3):. PubMed ID: 31330970
    [TBL] [Abstract][Full Text] [Related]  

  • 57. STAT1 participates in the induction of substance P expression in airway epithelial cells by respiratory syncytial virus.
    Luo YL; Wang S; Fang ZX; Nie YC; Zhang LT; Huang CQ; Long L; Lai KF
    Exp Lung Res; 2021; 47(2):78-86. PubMed ID: 33238771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses.
    Harcourt J; Alvarez R; Jones LP; Henderson C; Anderson LJ; Tripp RA
    J Immunol; 2006 Feb; 176(3):1600-8. PubMed ID: 16424189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice.
    Tahamtan A; Samieipoor Y; Nayeri FS; Rahbarimanesh AA; Izadi A; Rashidi-Nezhad A; Tavakoli-Yaraki M; Farahmand M; Bont L; Shokri F; Mokhatri-Azad T; Salimi V
    Virulence; 2018 Jan; 9(1):217-230. PubMed ID: 28992427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Toll-like receptor 4 expression and function of respiratory syncytial virus-infected airway epithelial cells].
    Xie XH; Liu EM; Yang XQ; Law HK; Li X; Wang LJ; Liu W; Xu WF
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Mar; 31(3):213-7. PubMed ID: 18785522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.